<DOC>
	<DOCNO>NCT01367782</DOCNO>
	<brief_summary>The purpose study test effect low frequency deep rTMS use novel H-coil motor , affective cognitive deficit patient asymmetric Parkinson 's disease ( PD ) , establish safety population test effect maintenance treatment .</brief_summary>
	<brief_title>A Double Blind Sham-controled Study Evaluate Influence Low Frequency Repetitive Transcranial Stimulation ( r-TMS ) Motor Cognitive Measurements Patients With Asymmetric Parkinson 's Disease</brief_title>
	<detailed_description>PD patient asymmetric disease age 40 year old , diagnose idiopathic PD accord UK Brain Bank criterion , Hoehn &amp; Yahr stag II - IV `` '' recruit . Participants antidepressant least 2 month stable therapy . Patient exclude : 1 . Patients concomitant epilepsy , history seizure heat convulsion history epilepsy first degree relative . 2 . Patients neuroleptic . 3 . Patients unstable medical disorder . 4 . History current unstable hypertension . 5 . History head injury neurosurgical intervention . 6 . History metal head ( outside mouth ) . 7 . Known history metallic particle eye , implanted cardiac pacemaker , implanted neurostimulators , surgical clip ( shoulder line ) medical pump . 8 . History migraine frequent severe headache . 9 . Current hearing loss . 10 . The presence cochlear implant 11 . Current drug abuse alcoholism . 12 . Pregnancy use reliable method birth control . 13 . Participation current clinical study clinical study within 30 day prior study . Patients randomize active rTMS arm sham stimulation arm . Each patient give 12 stimulation session , period 4 week , maintenance phase consist 8 stimulation session first 4 week additional 4 stimulation session follow 4 week . Active treatment H-coil include stimulation motor cortex ( 1 Hz stimulation 110 % motor threshold 15 minute ) prefrontal cortex ( 10Hz stimulation 100 % motor threshold , 2 second train , 20 second train , 15 minute ) . The control arm group receive sham stimulation identical treatment maintenance schedule . Patients sham group complete study give opportunity receive 12 session real r-TMS treatment 4 week treatment group . The following outcome measure take prior treatment ( screen visit ) , day 1 , 10 , 30 , 60 90 . Evaluation subject `` '' `` '' . Motor : 1 . Unified Parkinson 's Disease Rating Scale ( UPDRS ) 2 . Clinical Global Impression Severity ( CGIS ) 3 . Pegboard test . 4 . Tapping test 5 . Up &amp; Go test 6 . Abnormal Involuntary Movement Scale ( AIMS ) Mood affect 1 . Beck Depression Inventory ( BDI ) Cognition 1 . Mini mental State examination ( MMSE ) 2 . Digit forward backward test . 3 . Word fluency . 4 . Frontal Assessment Battery ( FAB ) Side effect closely monitor researcher promptly report IRB .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>PD patient asymmetric disease age 40 year old , diagnose idiopathic PD accord UK Brain Bank criterion , Hoehn &amp; Yahr stag II IV `` '' . Participants antidepressant least 2 month stable therapy . 1 . Patients concomitant epilepsy , history seizure heat convulsion history epilepsy first degree relative . 2 . Patients neuroleptic . 3 . Patients unstable medical disorder . 4 . History current unstable hypertension . 5 . History head injury neurosurgical intervention . 6 . History metal head ( outside mouth ) . 7 . Known history metallic particle eye , implanted cardiac pacemaker , implanted neurostimulators , surgical clip ( shoulder line ) medical pump . 8 . History migraine frequent severe headache . 9 . Current hearing loss . 10 . The presence cochlear implant 11 . Current drug abuse alcoholism . 12 . Pregnancy use reliable method birth control . 13 . Participation current clinical study clinical study within 30 day prior study .</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>UPDRS</keyword>
</DOC>